Pharmacovigilance:Master key for Drug Safety Monitoring - PowerPoint PPT Presentation

About This Presentation
Title:

Pharmacovigilance:Master key for Drug Safety Monitoring

Description:

Pharmacovigilance is only a medication security in clinical research. It is a logical strategy for assessing, comprehension, observing and avoiding unfriendly symptom of medication in a restorative preliminary. The word Pharmacovigilance is created from two words; in that "Pharmakon" is a Greek word which signifies "therapeutic substances" and "Vigilia" is a Latin word that signifies "to keep watch". – PowerPoint PPT presentation

Number of Views:80
Slides: 14
Provided by: shwetu
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Pharmacovigilance:Master key for Drug Safety Monitoring


1
PharmacovigilanceMaster key for Drug Safety
Monitoring
  • -ExlTech

2
Pharmacovigilance
3
Content
  • Introduction
  • Methods for Pharmacovigilance
  • Target Reporting
  • Cohort occasion observing
  • Singular case security reports
  • Clinical research of case reports
  • Part of Pharmacovigilance in Drug Development

4
What is Pharmacovigilance?
  • Pharmacovigilance is only a medication security
    in clinical research. It is a logical strategy
    for assessing, comprehension, observing and
    avoiding unfriendly symptom of medication in a
    restorative preliminary. The word
    Pharmacovigilance is created from two words in
    that "Pharmakon" is a Greek word which signifies
    "therapeutic substances" and "Vigilia" is a Latin
    word that signifies "to keep watch".

5
Methods for Pharmacovigilance
  • Target Reporting
  • Accumulations of individual case reports are
    unpredictable and heterogeneous. Not all reports
    are submitted to Pharmacovigilance frameworks by
    wellbeing experts, (for example, specialists,
    dental practitioners, medical attendants and drug
    specialists).
  • Some are distributed in diaries and others
    develop in relationship with claims. Coordinate
    patient announcing gives extra chances and
    difficulties. The nature of reports is variable,
    and some essential data is accessible just as
    free content, and not as organized database
    fields. Nitty gritty clinical survey is along
    these lines fundamental for viable information
    disclosure.

6
  • Cohort occasion observing
  • To supplement singular case reports, a few
    nations have executed partner occasion checking
    (CEM) frameworks for increased follow-up of
    chosen restorative items.
  • Cases incorporate New Zealand's Intensive
    Medicines Monitoring Program and remedy occasion
    checking in the UK.
  • The all around indicated accomplices, together
    with support to report all occasions, in a
    perfect world permit frequency rates to be
    evaluated and thought about crosswise over
    restorative items.

7
  • Singular case security reports
  • Singular case reports (in fact, 'singular case
    security reports', despite the fact that they
    manage hurts) incorporate reports to national
    administrative experts, for example, the yellow
    card arrangement of the Pharmacovigilance segment
    of the UK Medicines and Healthcare items
    Regulatory Agency and recounted reports in
    restorative diaries.
  • They impart certifiable worries about genuine
    speculated ADRs. Their quality in flagging causal
    relationship between therapeutic items and
    unfavorable occasions relies upon the expertise
    and experience of the correspondent

8
  • Clinical research of case reports
  • Accumulations of individual case reports are mind
    boggling and heterogeneous. Not all reports are
    submitted to Pharmacovigilance frameworks by
    wellbeing experts, (for example, specialists,
    dental specialists, medical caretakers and drug
    specialists).
  • Coordinate patient detailing gives extra chances
    and difficulties.
  • The nature of reports is variable, and some
    critical data is accessible just as free content,
    and not as organized database fields.

9
  • Part of Pharmacovigilance in Drug Development
  • Part of Pharmacovigilance in sedate improvement
    stage is recorded beneath.
  • 1.In Drug Discovery
  • 2.In Drug Development
  • 3.In Regulatory Review
  • 4.In Commercialization and showcasing
  • http//www.exltech.in/clinical-research-course
    .html

10
  • Drug Discovery
  • During the time spent medication revelation, the
    initial step is to distinguish a proper
    'medication' target which can be a biomolecule or
    a protein receptor that is unequivocally
    connected with a sickness condition or pathology.
  • This is trailed by testing of the objective
    against various little atom mixes to recognize
    lead mixes which can interface with the target
    biomolecule and show the potential restorative
    action either by invalidate or moderate the
    malady advancement.

11
  • 2.Drug Development
  • The medication improvement stage includes
    stringent testing and advancement of the chose
    mixes to distinguish the 'medication applicant'
    which may be most powerful as far as security,
    harmfulness , measurement, and adequacy in
    clinical research.
  • The effective lead competitor must be
    non-harmful and ought to have great
    bioavailability, can be disseminated to the
    medication focus in the body, and can be
    processed productively and adequately and
    additionally effectively discharged from the body.

12
  • 3.Regulatory Review and Approval
  • The result of the 'clinical preliminary' chooses
    whether the medication hopeful is more secure
    what's more, sufficiently powerful in treating
    the malady.
  • They have to endorse the medication applications
    with the goal that the organization can
    popularize the medication in their locales (e.g.,
    a New Drug Application (NDA) in USA, and
    Marketing Authorization Application (MAA) in
    Europe)

13
  • Thank You

For more Information visit http//www.exltech.in/
Write a Comment
User Comments (0)
About PowerShow.com